# Impact of the aging niche on cancer phenotypes probed using mouse cancer models produced by somatic engineering.

> **NIH NIH U01** · SLOAN-KETTERING INST CAN RESEARCH · 2022 · $517,800

## Abstract

SUMMARY
Aging is the greatest risk factor for cancer development, yet the physiological and molecular mechanisms
underlying this relationship remain poorly understood. Undoubtedly, one contributing factor is time – i.e. the
years or decades needed for a single cell to acquire sufficient mutations to trigger overt disease. However,
other factors certainly play a role, including age-related changes in cell metabolism, DNA damage responses,
immune cell function, and the abundance of senescent cells. While understanding how these factors influence
tumorigenesis will reveal strategies to improve cancer intervention and treatment, facile models to study cancer
in aged animals are lacking. Addressing this critical challenge, we incorporate somatic tissue engineering
methods to introduce oncogenic mutations directly into the organs of aged mice, thereby obviating the time and
costs of intercrossing and aging cohorts of multi-allelic genetically engineered mouse models (GEMMs). We
have developed a range of such “non-germline GEMMs” (nGEMMs) of different target organs and cancer
genotypes and shown that the resulting cancers recapitulate molecular and histological features of the
corresponding human disease. We have also produced nGEMMs using aged mice and shown that the
developing tumors have distinct immune infiltrates with different tumor surveillance capabilities. This proposal
combines the unique capabilities of nGEMMs with state-of-the-art tissue analyses to assess the contribution of
the aged environment to cancer manifestation in different organ contexts and compares results to settings in
which dietary or genetic factors uncouple biological age from chronological age. Implementation of advanced
single cell methods will produce a detailed picture of cell type and cell state differences in tumors developing in
aged animals and perturbation studies will explore tumor cell intrinsic and extrinsic factors underlying age-
related phenotypes. The proposed experiments will benefit from combining our expertise in cancer biology with
that of Dr. Laura Niedernhofer, who has extensive experience in studying organismal aging. Our studies will
establish broadly portable models for studying cancer in aged mice at a breadth and pace that was previously
impossible and produce novel insights into how the epigenetic and physiological processes linked to age
contribute to an increase in cancer incidence and/or progression.

## Key facts

- **NIH application ID:** 10491933
- **Project number:** 5U01AG077921-02
- **Recipient organization:** SLOAN-KETTERING INST CAN RESEARCH
- **Principal Investigator:** SCOTT W. LOWE
- **Activity code:** U01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $517,800
- **Award type:** 5
- **Project period:** 2021-09-30 → 2026-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10491933

## Citation

> US National Institutes of Health, RePORTER application 10491933, Impact of the aging niche on cancer phenotypes probed using mouse cancer models produced by somatic engineering. (5U01AG077921-02). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10491933. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*